SWOG clinical trial number
SWOG-9246

A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma

Closed
Phase
Accrual
58%
Published
Abbreviated Title
A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma
Activated
03/01/1993
Closed
12/01/1995

Publication Information Expand/Collapse

1998

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.

OW Press;M LeBlanc;TJ O'Rourke;S Gagnet;RA Chapman;SP Balcerzak;RI Fisher Journal of Clinical Oncology 16(2):574-578

Paclitaxel for the treatment of lymphoma.

A Younes Journal of Clinical Oncology 16(6):2289-2290

Paclitaxel for the treatment of lymphoma. In reply.

OW Press Journal of Clinical Oncology 16(6):2290